ALBANY MOLECULAR RESEARCH HYDERABAD RESEARCH CENTR

Company Type:

It is a Contract Research Organization (CRO) and Research and Development (R&D) center, not a factory or a trader.

Company Introduction:

Albany Molecular Research Hyderabad Research Center is a significant facility that was part of Albany Molecular Research Inc. (AMRI), a global contract research and manufacturing organization (CRO/CMO). AMRI was renowned for providing comprehensive services to the pharmaceutical and biotechnology industries worldwide. The Hyderabad Research Center, located in India, specialized in various aspects of drug discovery and development. Its core activities included medicinal chemistry, synthetic chemistry, process research and development, custom synthesis, and analytical services. The center played a crucial role in supporting clients' drug development pipelines, from early-stage discovery to preclinical and clinical development, by offering expertise in complex chemical synthesis and integrated drug discovery solutions. Following its acquisition, AMRI was rebranded as Curia, and the Hyderabad center now operates under the Curia brand, continuing its legacy of scientific excellence and innovation in pharmaceutical research and development.

ALBANY MOLECULAR RESEARCH HYDERABAD RESEARCH CENTER, as a contract research, development, and manufacturing organization (CRDMO), does not produce or sell consumer products. Instead, it offers specialized services to pharmaceutical and biotechnology companies. These services include:

Discovery Chemistry Services (e.g., medicinal chemistry, synthetic chemistry)

Process Chemistry Development

Analytical Chemistry Services

Biology Services (e.g., in vitro pharmacology, assay development)

Custom Synthesis of Active Pharmaceutical Ingredients (APIs) and intermediates

Early-stage Drug Development Services